title: Tolerability of abacavir in the clinical setting.
authors.affiliation: Service of Infectious Diseases, Hospital Carlos III, Instituto de Salud Carlos III, Madrid, Spain.
authors.forename: L
authors.initials: L
authors.lastname: Martín-Carbonero
authors.forename: P
authors.initials: P
authors.lastname: Barreiro
authors.forename: V
authors.initials: V
authors.lastname: Soriano
authors.forename: J
authors.initials: J
authors.lastname: González-Lahoz
mesh_terms: D015224:Dideoxynucleosides / Q000009:adverse effects* / Q000627:therapeutic use; D004357:Drug Synergism; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D019055:No-Observed-Adverse-Effect Level; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D012449:Safety; D000099227:Abacavir
chemical_list: D015224:Dideoxynucleosides; D018894:Reverse Transcriptase Inhibitors; D000099227:Abacavir